Cardiac Allografts
Rejection of B6.H-2bm12 heart allografts is inhibited by regulatory cells
Published in Medical Devices and Surgical Technology Week, May 22nd, 2005
According to published research from the United States, "Skin but not vascularized cardiac allografts from B6.H-2bm12 mice are acutely rejected by C57BL/6 recipients in response to the single class II MHC disparity. The underlying mechanisms preventing acute rejection of B6.H-2bm12 heart allografts by C57BL/6 recipients were investigated."
S. Schenk and colleagues of the Cleveland Clinic Foundation reported, "B6.H-2bm12 heart allografts induced low...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Acute Myocardial Infarction
23Na MRI useful for monitoring infarct healing - Cardiac Devices
Induction ovens do not interfere with ICD function - Laser-Accelerated Proton Therapy
Compact particle selection/beam collimation system devised - Magnesium Deficiency
Novel assay enables assessment of intracellular magnesium levels - Therapeutic Ultrasound
US treatment affects osteoblast integrin expression and differentiation - ACE Inhibitors
ACE-inhibitory peptides were isolated from soybean protein hydrolysates - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
